Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

2.60
+0.18007.44%
Post-market: 2.660.0589+2.27%16:57 EDT
Volume:220.05K
Turnover:543.57K
Market Cap:90.18M
PE:-2.09
High:2.63
Open:2.38
Low:2.33
Close:2.42
Loading ...

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

GlobeNewswire
·
10 Feb

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory

Insider Monkey
·
25 Jan

ACHV: Long-Term Exposure Requirement Complete

Zacks Small Cap Research
·
21 Jan

Achieve Life Sciences appoints Slaoui, Phelan to board of directors

TIPRANKS
·
10 Jan

Achieve Life Sciences Appoints DR. Kristen Slaoui and Nancy Phelan to Its Board of Directors

THOMSON REUTERS
·
10 Jan

Press Release: Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

Dow Jones
·
10 Jan

Achieve Life Sciences Reaches Milestone in Clinical Trial for Smoking Cessation Drug

MT Newswires Live
·
08 Jan

Achieve Life Sciences (ACHV) Gets a Buy from JonesTrading

TIPRANKS
·
07 Jan

Achieve Life Sciences Inc - FDA Requests Six-Month Safety Exposure Data for Nda Submission

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - Cytisinicline Nda Submission on Target for Q2 2025

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - on Track for Nda Submission in Q2 2025

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Announces Critical Milestone Successfully Reached in Orca-Ol Cytisinicline Clinical Trial Required for Nda Submission

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - No Safety Concerns Identified in Orca-Ol Trial

THOMSON REUTERS
·
07 Jan

Achieve Life Sciences Inc - Orca-Ol Trial Evaluates Long-Term Safety of 3 Mg Cytisinicline Dosing

THOMSON REUTERS
·
07 Jan

Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1?

Insider Monkey
·
03 Jan

Achieve Life Sciences, Inc. (NASDAQ:ACHV) down to US$131m market cap, but institutional owners may not be as affected after a year of 0.5% returns

Simply Wall St.
·
21 Dec 2024

Achieve Life Sciences Appoints Mark Oki CFO

MT Newswires Live
·
09 Dec 2024

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

THOMSON REUTERS
·
09 Dec 2024

Press Release: Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Dow Jones
·
09 Dec 2024

Achieve Life Sciences announces outcome of End-of-Phase 2 meeting with FDA

TIPRANKS
·
03 Dec 2024